Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KCK Medical Technologies Group, often referred to as KCK MedTech, is the specialized medical technology investment arm of KCK Group, a multi-billion dollar family office. The firm focuses on partnering with revolutionary medical device and life science companies to transform healthcare standards through long-term commitment and experienced operational support. Their investment team is comprised of former operators with extensive leadership experience in both Fortune 500 and startup medtech environments. KCK MedTech typically participates in growth-stage and late-stage venture rounds, supporting companies through commercialization and beyond. Notable portfolio companies include Sight Sciences, NeuroPace, RefleXion Medical, and Aerin Medical, spanning therapeutic areas such as ophthalmology, neurology, and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KCK Medical Technologies Group.